Literature DB >> 18461294

[Examples of screening investigations].

A Eickhoff1, A Hahn, J F Riemann.   

Abstract

Primary prevention of cancer still only finds limited acceptance in the general population, therefore, secondary prevention plays an important role in order to avoid the high costs necessary for the treatment of advanced forms of cancer. Breast cancer, prostate cancer and colorectal carcinoma (CRC) are the most common forms of cancer with high mortality and a high socio-economic impact. Screening tests for these diseases are effective and simple to carry out. The measures for secondary prevention are well known but are only implemented to approximately 30-40%. For persons over 55 years old routine screening at 10-year intervals by ileocoloscopy is now established for CRC, or alternatively an annual examination for occult blood in faeces (FOBT) over 50 years of age. Screening mammography for women aged between 50 and 69 years old is firmly established in the guidelines of the Gemeinsamer Bundesausschuss since 2004 for early recognition of cancer. It is anticipated that the establishment of the screening programme in Germany will be completed in all Federal States by the end of March 2008. All men over 45 years of age who are compulsory insured are entitled to have an annual examination of the external genital organs and a digital rectal examination of the prostate under the compulsory cancer early recognition programme. PSA testing within the framework of preventive examinations is, however, not yet part of the catalogue of available tests.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461294     DOI: 10.1007/s00108-008-2163-3

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

1.  The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up.

Authors:  L Tabár; B Vitak; H H Chen; S W Duffy; M F Yen; C F Chiang; U B Krusemo; T Tot; R A Smith
Journal:  Radiol Clin North Am       Date:  2000-07       Impact factor: 2.303

2.  Trends in breast cancer incidence, survival, and mortality.

Authors:  M P Coleman
Journal:  Lancet       Date:  2000-08-12       Impact factor: 79.321

Review 3.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

4.  Cancer incidence and mortality in Europe, 2004.

Authors:  P Boyle; J Ferlay
Journal:  Ann Oncol       Date:  2005-02-17       Impact factor: 32.976

5.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

6.  Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy.

Authors:  Dirk Hartmann; Boris Bassler; Dieter Schilling; Henning E Adamek; Ralf Jakobs; Barbara Pfeifer; Axel Eickhoff; Christoph Zindel; Jürgen F Riemann; Günter Layer
Journal:  Radiology       Date:  2005-11-22       Impact factor: 11.105

7.  Long term follow-up of mass screening for prostate carcinoma in men with initial prostate specific antigen levels of 4.0 ng/ml or less.

Authors:  K Ito; Y Kubota; T Yamamoto; K Suzuki; Y Fukabori; K Kurokawa; H Yamanaka
Journal:  Cancer       Date:  2001-02-15       Impact factor: 6.860

8.  Variability in the interpretation of screening mammograms by US radiologists. Findings from a national sample.

Authors:  C A Beam; P M Layde; D C Sullivan
Journal:  Arch Intern Med       Date:  1996-01-22

9.  One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Authors:  D A Lieberman; D G Weiss
Journal:  N Engl J Med       Date:  2001-08-23       Impact factor: 91.245

10.  Genetic analysis of breast cancer in the cancer and steroid hormone study.

Authors:  E B Claus; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

View more
  1 in total

1.  [Spleen ruptures after screening colonoscopy].

Authors:  P Stauch; P Dietrich; M Bernhard; D Jaspersen; A Gries; A Hellinger
Journal:  Chirurg       Date:  2010-08       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.